Abstract Library

#1585 Incidence and Characteristics of Ileo-colonic Neuroendocrine Tumours Identified in the UK Bowel Cancer Screening Programme

Introduction: Colorectal cancer is the third most common cancer in the UK this had led to development of the bowel cancer screening programmes (BCSPs).There are few epidemiological data on rectal or ileal NETs diagnosed in BCSPs.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Srirajaskanthan R

Authors: Basuroy R, O'Donnell K, Brooks C, Srirajaskanthan R, Ramage J,

Keywords: screening,

#1459 Does Faecal Occult Blood Testing Help Identify Ileo-Colonic NETs in the UK Bowel Cancer Screening Programme (BCSP)?

Introduction: There has been an increase in the incidence of ileo-colonic NETs in recent years, partly from endoscopy. There is no published data on the incidence of NETs diagnosed in the UK ‘double’ screen BCSP of initial Faecal Occult Blood stool test (FOBt) and, if abnormal, colonoscopy. The incidence (per 100k) of colorectal cancer (CRC) in FOBt abnormal UK BCSP colonoscopy is 55 times that of the population incidence (10k vs 184).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Basuroy R, O'Donnell K, Brooks C, Srirajaskanthan R, Ramage J,

Keywords: Bowel Cancer Screening, Ileo-colonic, NETs, Rectal,

#1169 Revalidation of QLQC30 and GINET21 Module in Patients with Neuroendocrine Tumors Using Online Questionnaire

Introduction: The GINET21 module measures PROMS for patients with NETs and was validated from 2006, since when there have been rapid changes in cancer therapeutics. Current module revalidation methodology a time and resource-intensive process, which may lag behind these treatment

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author:

Authors: Kaupp-Roberts S, Gray D, O'Donnell K, Bouvier C, Ramage J,

Keywords: QoL PROM,